| Course | NUR-7600 Psychopharmacology and Neuroscience Foundations Across the Lifespan |
|---|---|
| Module | Module 6 |
| Paper type | Prescribing case: toxicity and long-term monitoring |
| Length | About 1,031 words, 6 pages |
| Format | APA 7 student paper |
| School | Thomas Edison State University |
| Program | M.S. in Nursing, Psychiatric Mental Health Nurse Practitioner |
| Updated | October 2026 |
Free sample paper for NUR 7600 Module 6
A Level of 1.6 After a New Blood Pressure Pill: Lithium Toxicity, Drug Interactions and Why a 41-Year-Old With Bipolar I Disorder Should Stay on Lithium
Student Name
M.S. in Nursing, Psychiatric Mental Health Nurse Practitioner, Thomas Edison State University
NUR-7600: Psychopharmacology and Neuroscience Foundations Across the Lifespan
Mentor Name
Month Day, Year
A Level of 1.6 After a New Blood Pressure Pill: Lithium Toxicity, Drug Interactions and Why a 41-Year-Old With Bipolar I Disorder Should Stay on Lithium
Introduction
Mr. S. is an invented patient, a 41-year-old line supervisor at a food distribution warehouse in Camden. He was diagnosed with bipolar I disorder at 29 after a manic episode that cost him a job and a hospitalization. He has taken lithium carbonate 900 milligrams daily for six years, with levels between 0.6 and 0.8 millimoles per liter and no mood episodes. Two weeks ago his primary care clinician started lisinopril 10 milligrams for blood pressure of 148/94, and a week ago he strained his back and began taking ibuprofen 400 milligrams three times a day. Over three days he developed a coarse tremor, loose stools and unsteadiness on the warehouse floor. Twelve hours after his last capsule his lithium reads 1.6, and his creatinine has crept from 0.9 to 1.2. This paper explains what happened, manages it and decides whether he should continue lithium.
How the Body Handles Lithium
Lithium is a small ion that is not metabolized. It is filtered by the kidneys and largely reabsorbed in the proximal tubule along with sodium. Anything that makes the kidney hold on to sodium, or that lowers filtration, makes it hold on to lithium too. Because the range between a therapeutic level and a toxic one is narrow, small changes in renal handling can push a stable patient into toxicity. For maintenance, levels are usually kept between about 0.6 and 0.8 millimoles per liter, and toxicity becomes likely above 1.2 to 1.5.
What Raised His Level
Two new drugs acted together. Angiotensin-converting enzyme inhibitors such as lisinopril reduce aldosterone and can lower the glomerular filtration rate, and the body's response to mild sodium loss is to increase proximal reabsorption of sodium, and lithium with it. Nonsteroidal anti-inflammatory drugs such as ibuprofen reduce prostaglandins that maintain blood flow to the kidney, lowering filtration and lithium clearance. Each can raise lithium levels; together, with the warm conditions of a warehouse in summer and possible dehydration, they raised his level from 0.7 to 1.6. His rise in creatinine reflects the same reduced filtration.
The timing fits as well. Lithium levels change over several days after a new interacting drug, because the drug's half-life of about a day means a new steady state takes most of a week to reach. Symptoms that began a week or two after lisinopril and within days of starting ibuprofen are the pattern expected when clearance falls in two steps.
Managing the Toxicity
His symptoms, coarse tremor, diarrhea and mild ataxia without confusion, indicate mild to moderate toxicity. Lithium is held. Ibuprofen is stopped and acetaminophen used for his back. His primary care clinician is called, and lisinopril is replaced with amlodipine, which does not affect lithium handling. He is given oral fluids and his level, electrolytes and creatinine are repeated in 24 hours. Had he been confused, vomiting or unable to drink, or had his level been higher, he would have been sent to the emergency department for intravenous fluids and evaluation for hemodialysis, which is used in severe toxicity. When his level falls below 0.8 and symptoms resolve, lithium is restarted at his previous dose with a level checked in five to seven days.
Long-Term Effects
McKnight et al. (2012) assembled 385 studies on what long-term lithium does to the body. The kidney's power to concentrate urine fell, which is why so many patients feel thirsty and urinate often; filtration dropped slightly on average, and kidney failure was rare, with about one patient in 200 needing dialysis. Clinical hypothyroidism was markedly more common in lithium users, and lithium raised calcium and parathyroid hormone. Weight gain was more common than with placebo.
For Mr. S., these findings set the monitoring schedule but do not argue against lithium. His kidney function was normal before this episode, his thyroid has been checked yearly and his weight has been stable. The rise in creatinine during toxicity should return to baseline, and if it does not, his psychiatric and primary care clinicians will weigh renal risk against psychiatric benefit together.
| Test | Purpose | Schedule for Mr. S. |
|---|---|---|
| Lithium level | Keep in 0.6 to 0.8 range | Every 3 to 6 months, and after any new drug or illness |
| Creatinine and eGFR | Renal function | Every 6 months |
| TSH | Hypothyroidism | Every 6 to 12 months |
| Calcium | Hyperparathyroidism | Yearly |
| Weight | Weight gain | Each visit |
Why He Should Stay on Lithium
An episode of toxicity raises the question of stopping lithium. The evidence argues against it. Geddes et al. (2004) combined five maintenance trials and found about a third fewer relapses on lithium than on placebo, most clearly for mania. Cipriani et al. (2013) brought together 48 randomized trials and found fewer suicides and fewer deaths overall on lithium than on placebo among people with mood disorders, a benefit no other mood stabilizer has shown as clearly. Mr. S. has been well for six years on lithium, and his previous mania was severe. The toxicity was caused by preventable interactions, not by lithium at a stable dose.
Preventing a Recurrence
Mr. S. keeps a wallet card naming four drug groups he must clear with his psychiatric prescriber first: anti-inflammatory pain relievers, ACE inhibitors, angiotensin blockers and thiazide water pills. He is taught the early signs of toxicity, to drink extra fluids in hot weather and during illness, and to hold lithium and call if he has vomiting or diarrhea. His primary care clinician and pharmacy are informed, and a drug interaction alert is added to his record.
His sister, who fills his pill organizer each Sunday, is shown the wallet card too, so a second pair of eyes catches a new pain reliever or blood pressure pill before he starts it.
Conclusion
Mr. S.'s lithium level rose to 1.6 because two common drugs reduced its renal clearance. His toxicity was managed by holding lithium, stopping the interacting drugs and monitoring until levels fell. Long-term renal, thyroid and calcium effects are monitored on a schedule, and the strong evidence for relapse and suicide prevention supports restarting lithium with better coordination of his care.
References
Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013). Lithium in the prevention of suicide in mood disorders: Updated systematic review and meta-analysis. BMJ, 346, f3646. https://doi.org/10.1136/bmj.f3646
Geddes, J. R., Burgess, S., Hawton, K., Jamison, K., & Goodwin, G. M. (2004). Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trials. American Journal of Psychiatry, 161(2), 217-222. https://doi.org/10.1176/appi.ajp.161.2.217
McKnight, R. F., Adida, M., Budge, K., Stockton, S., Goodwin, G. M., & Geddes, J. R. (2012). Lithium toxicity profile: A systematic review and meta-analysis. The Lancet, 379(9817), 721-728. https://doi.org/10.1016/S0140-6736(11)61516-X
Reading the NUR 7600 Module 6 assignment instructions
The final module of this planning rail takes the catalog's mention of toxicity to a drug whose safe and dangerous levels sit close together, since no published syllabus fixes a different topic. Expect a case paper that explains the drug's kinetics, identifies the cause of toxicity, manages it safely with clear criteria for emergency referral, sets a long-term monitoring schedule and weighs whether to continue the drug against its benefits. Some classrooms use valproate, carbamazepine or clozapine instead. Check the directions. Explain interactions through mechanism, coordinate with the other prescribers involved and base the decision to continue or stop on evidence, not on the fright of one event. State when each level was drawn.
How this NUR 7600 Module 6 example is built
The case opens with a line supervisor stable on lithium for six years who develops tremor, diarrhea and unsteadiness after starting lisinopril and ibuprofen, with a level of 1.6. A section explains renal handling of lithium and its narrow range. The interaction section links each new drug to reduced clearance. Management holds lithium, stops ibuprofen, switches the antihypertensive and sets criteria for emergency care. A review of 385 studies supports a five-row monitoring table. Relapse and suicide evidence supports continuing lithium, and the paper ends with a plan to prevent recurrence through teaching, a drug card and coordination with primary care. The timing of his symptoms is explained through lithium's half-life.
Reading the NUR 7600 Module 6 grading rubric
Toxicity cases are graded on accurate pharmacokinetics, correct identification of the cause, safe management with clear escalation criteria, a complete long-term monitoring plan and a reasoned decision about continuing the drug. Mentors look for interactions explained through mechanism and for coordination with other prescribers. Weighing toxicity against the drug's proven benefits shows clinical judgment. Patient teaching on early signs and situations that raise risk is expected. Accurate levels, units and sampling time, and current sources with APA formatting, complete the grade. A monitoring table with intervals is usually credited, and explaining the timing of symptoms through the drug's half-life shows real understanding of kinetics.
NUR 7600 Module 6 help from the desk
Students often list lithium interactions without explaining why they occur. Explain renal handling and the interactions follow. Report the timing of every level, since lithium is measured as a trough roughly 12 hours after a dose. Do not stop an effective drug without weighing its benefits. Give clear criteria for sending a patient to the emergency department. Include long-term renal, thyroid and calcium monitoring with intervals. Tell the primary care clinician. Teach the patient which drugs to avoid, and explain why symptoms appeared when they did. Recheck renal function after the episode. Narrow-range drugs such as lithium, valproate or clozapine can all be worked the same way; send the NUR-7600 case and the first draft is on us.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official Thomas Edison State University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
More NUR 7600 and M.S. in Nursing, Psychiatric Mental Health Nurse Practitioner sample papers
- NUR 7600 Module 1: Neurotransmission Case: Why a First SSRI Takes Weeks to Help
- NUR 7600 Module 2: Pharmacogenetics Case: A CYP2C19 Ultrarapid Metabolizer on Escitalopram
- NUR 7600 Module 3: Antipsychotic Case: First-Episode Psychosis and Metabolic Risk
- NUR 7600 Module 4: Lifespan and Controlled Substances Case: Methylphenidate for a 9-Year-Old
- NUR 7600 Module 5: Adverse Events Case: Risperidone, the Boxed Warning and a Taper in Dementia
- NUR 7610 Module 5: Ethics and Law Paper: Outpatient Commitment and the Duty to Protect
- NUR 7631 Module 2: Adolescent Depression Case: Fluoxetine, CBT and the Suicidality Warning
- NUR 7620 Module 4: Group Therapy Case: Dialectical Behavior Therapy for Self-Harm
- NUR 7633 Module 4: Late-Life Anxiety Case: Benzodiazepine Deprescribing, Beers Criteria and Escitalopram
NUR 7600 Module 6 questions, answered
Where can I find a free NUR 7600 Module 6 sample paper?
All of it is printed here. It manages a lithium level of 1.6 caused by lisinopril and ibuprofen and decides to continue lithium.
Which drugs raise lithium levels?
Anything that makes the kidney hold sodium or filter less: anti-inflammatory pain relievers, ACE inhibitors and angiotensin blockers, thiazides, and dehydration from heat or diarrhea.
What is the therapeutic lithium level for maintenance?
Usually about 0.6 to 0.8 mmol/L, measured about 12 hours after the last dose. Toxicity becomes likely above about 1.2 to 1.5.
What monitoring does lithium need?
Lithium levels every 3 to 6 months and after changes, kidney function every 6 months, thyroid function every 6 to 12 months, calcium yearly and weight at each visit.
Does lithium reduce suicide?
Yes. Pooled trials show fewer suicides and fewer deaths from all causes among people with mood disorders who take lithium than among those on placebo.